title: Salivary glands and noradrenergic transmission in diabetic rats.
abstract: 1 Type 2 diabetes is associated with diverse oral pathologies in which salivary flow reduction is one of the causes of these oral abnormalities. Scarce literature exists regarding noradrenergic transmission and adrenergic-induced salivary flow in submaxillary and parotid glands of type 2 diabetic rats. 2 We studied noradrenergic transmission as well as the secretory response to alpha1- and beta-adrenoceptor stimulation in the parotid and submaxillary glands of type 2 diabetic rats. 3 Diabetic rats exhibited diminished neuronal uptake, release and endogenous content of noradrenaline (NE) in both salivary glands. Further, NE synthesis was also diminished accompanied by decreased tyrosine hydroxylase activity. Salivary flow responses to alpha1-(methoxamine) and beta-(isoprenaline) adrenoceptor stimulation were reduced in the submaxillary as well as the parotid glands of diabetic rats. 4 Our results suggest that the reduction of noradrenergic transmission in the salivary glands of type 2 diabetic rats is in part responsible for the diminished salivary flow evoked by alpha1- and beta-adrenergic stimulation. Reduced noradrenergic activity may contribute to the pathophysiology of oral abnormalities in diabetic patients.
authors.affiliation: Catedra de Fisiologia, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junin 956-7mo piso, 1113 Buenos Aires, Argentina.
authors.forename: M S
authors.initials: MS
authors.lastname: Vatta
authors.forename: S I
authors.initials: SI
authors.lastname: Hope
authors.forename: G M
authors.initials: GM
authors.lastname: Prendes
authors.forename: L G
authors.initials: LG
authors.lastname: Bianciotti
authors.forename: J C
authors.initials: JC
authors.lastname: Elverdin
authors.forename: B E
authors.initials: BE
authors.lastname: Fernandez
mesh_terms: D000322:Adrenergic Agonists / Q000494:pharmacology; D058646:Adrenergic alpha-1 Receptor Agonists; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D012469:Salivary Glands / Q000187:drug effects / Q000378:metabolism*
chemical_list: D000322:Adrenergic Agonists; D058646:Adrenergic alpha-1 Receptor Agonists; D018340:Receptors, Adrenergic, alpha-1; D011943:Receptors, Adrenergic, beta; D009638:Norepinephrine